UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Commentary on Improving the Efficiency of Clinical Pharmacology Studies

Clinical pharmacology in drug development, 2023-08, Vol.12 (8), p.775-778

Fossler, Michael J.

2023

Volltextzugriff (PDF)

Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings

Journal of clinical pharmacology, 2008-05, Vol.48 (5), p.632-649

2008

Volltextzugriff (PDF)

The Importance of Participant Tracking When Conducting Clinical Pharmacology Drug Trials

Journal of clinical pharmacology, 2022-12, Vol.62 (12), p.1465-1467

2022

Volltextzugriff (PDF)

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach

Frontiers in pharmacology, 2019-07, Vol.10, p.785-785

2019

Volltextzugriff (PDF)

Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine

Anesthesiology (Philadelphia), 2020-09, Vol.133 (3), p.559-568

2020

Volltextzugriff (PDF)

Patient adherence: Clinical pharmacology's embarrassing relative

Journal of clinical pharmacology, 2015-04, Vol.55 (4), p.365-367

Fossler, Michael J.

2015

Volltextzugriff (PDF)

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

Journal of pain research, 2017-01, Vol.10, p.2413-2424

2017

Volltextzugriff (PDF)

Functionally Selective Inhibition of the Oxytocin Receptor by Retosiban in Human Myometrial Smooth Muscle

Endocrinology (Philadelphia), 2020-02, Vol.161 (2), p.1

2020

Volltextzugriff (PDF)

Edible Cannabis Products: It Is Time for FDA Oversight

Journal of clinical pharmacology, 2016-09, Vol.56 (9), p.1045-1047

2016

Volltextzugriff (PDF)

A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects

CNS drugs, 2020-08, Vol.34 (8), p.853-865

2020

Volltextzugriff (PDF)

Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis

Therapeutic drug monitoring, 2018-04, Vol.40 (2), p.212-221

2018

Volltextzugriff (PDF)

Oliceridine (TRV130), a Novel G Protein–Biased Ligand at the μ‐Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model

Journal of clinical pharmacology, 2018-06, Vol.58 (6), p.750-761

2018

Volltextzugriff (PDF)

The Potential Role of the J-T peak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium

Journal of clinical pharmacology, 2019-07, Vol.59 (7), p.909-914

2019

Volltextzugriff (PDF)

The Potential Role of the J‐Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium

Journal of clinical pharmacology, 2019-07, Vol.59 (7), p.909-914

2019

Volltextzugriff (PDF)

Population Pharmacokinetics of Pemetrexed in Adult Non–Small Cell Lung Cancer in Indian Patients

Journal of clinical pharmacology, 2019-09, Vol.59 (9), p.1216-1224

2019

Volltextzugriff (PDF)

Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk

Heart rhythm, 2021-12, Vol.18 (12), p.2177-2186

2021

Volltextzugriff (PDF)

Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain

Clinical drug investigation, 2020-08, Vol.40 (8), p.755-764

2020

Volltextzugriff (PDF)

A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms

The AAPS journal, 2013-10, Vol.15 (4), p.1072-1081

2013

Volltextzugriff (PDF)

Infusions Are the Optimal Dosing Method in Intravenous ADME Studies Rather Than Bolus Dosing

Journal of clinical pharmacology, 2018-01, Vol.58 (1), p.25-28

2018

Volltextzugriff (PDF)

Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study

Thrombosis and haemostasis, 2002-05, Vol.87 (5), p.817-823

2002

Volltextzugriff (PDF)

Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events

Expert review of pharmacoeconomics & outcomes research, 2022-05, Vol.22 (4), p.671-681

2022

Volltextzugriff (PDF)

A Systematic Evaluation of Effect of Adherence Patterns on the Sample Size and Power of a Clinical Study

CPT: pharmacometrics and systems pharmacology, 2018-12, Vol.7 (12), p.818-828

2018

Volltextzugriff (PDF)

Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose‐ranging study

British journal of clinical pharmacology, 2017-10, Vol.83 (10), p.2283-2291

2017

Volltextzugriff (PDF)

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine

Clinical pharmacology in drug development, 2020-07, Vol.9 (5), p.639-650

2020

Volltextzugriff (PDF)

Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain

Journal of comparative effectiveness research, 2021-10, Vol.10 (15), p.1107-1119

2021

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(74)

Sprache

Englisch
(74)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Commentary on Improving the Efficiency of Clinical Pharmacology Studies

Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings

The Importance of Participant Tracking When Conducting Clinical Pharmacology Drug Trials

Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach

Benefit and Risk Evaluation of Biased μ-Receptor Agonist Oliceridine versus Morphine

Patient adherence: Clinical pharmacology's embarrassing relative

A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty

Functionally Selective Inhibition of the Oxytocin Receptor by Retosiban in Human Myometrial Smooth Muscle

Edible Cannabis Products: It Is Time for FDA Oversight

A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects

Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis

Oliceridine (TRV130), a Novel G Protein–Biased Ligand at the μ‐Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model

The Potential Role of the J-T peak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium

The Potential Role of the J‐Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium

Population Pharmacokinetics of Pemetrexed in Adult Non–Small Cell Lung Cancer in Indian Patients

Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk

Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain

A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms

Infusions Are the Optimal Dosing Method in Intravenous ADME Studies Rather Than Bolus Dosing

Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study

Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events

A Systematic Evaluation of Effect of Adherence Patterns on the Sample Size and Power of a Clinical Study

Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose‐ranging study

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Oliceridine

Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain

Suchergebnisse filtern